FROM THE EDITOR

Abstract

This issue closes the creative publication year for the Editorial Board. In this regard, we, like all our readers, summarize and analyze the results of our work

Full Text

Igor Narkevich

Chairman of the Editorial Council

In addition to the main task of increasing the publication activity of scientists, teachers and students in the field of pharmacy by providing the pages of the Journal for posting materials and methodological assistance in the design of scientific publications, we were able, with the support of the Saint Petersburg State Chemical and Pharmaceutical University, to implement a pilot project on the environmental safety in the pharmaceutical industry. This is the Scientific and Practical Forum “Environmental Protection”. We hope that this event will be held annually at the sites of our university.

Considering the relevance of the explosive development of nuclear medicine in our country and the fact that the use of radiopharmaceutical drugs (RPCD) plays a key role in this area of medicine and is not only of interdisciplinary importance, but also provides interdisciplinary communication, our Forum has been held for the first time in June in the full-time conference format on the topic “Environmental Protection. Environmental Risks Assessment in the Radiopharmaceuticals Waste Management”.

In December, within the framework of the Forum, a Round Table was held on the topic “Environmental Protection. Environmental Risks Assessment at Nuclear Medicine Facilities and Experimental Pharmacology Centers”. It was held at the authoritative venue of the Saint Petersburg State Chemical and Pharmaceutical University in a full-time and part-time format. Scientists from Saint Petersburg universities and scientific medical institutions have discussed their achievements in the field of application of innovative technologies for ensuring radiation safety in the course of the RPCD development and production.

Participants of the Scientific and Practical Forum “Environmental Protection” have presented the results of scientific research in the field of nuclear medicine, analyzed the practice of their application abroad and in Russia, outlined the vectors for the development of domestic innovative areas in specialized diagnostics, proton therapy, preclinical studies of radiopharmaceutical drugs, training specialists for nuclear medicine facilities.

The domestic pharmaceutical industry is focused on the patient. The health and safety of our patients is always a priority for us. The radiopharmaceutical must be effective and safe. Particular attention should be paid to the organization of radiation safety during its entire life cycle, from development to application in practical medical activities.

The speeches of the participants of the Scientific and Practical Forum “Environmental Protection” have demonstrated the innovative nature of the approaches to the new RPCD development and the competitiveness of domestic developers in comparison with foreign colleagues.

The scientific and practical Forum has shown that a correctly chosen topic for discussion allows specialists from the departments of radioactive and radiation diagnostics, nuclear medicine facilities and pharmaceutical industry employees to exchange experience in terms of using advanced medical and pharmaceutical practices, solving issues of providing RPCD patients, training highly qualified personnel, developing legislative bases. Thus, a consolidated position of scientists, medical practitioners, government officials and the business community may be formed to start effective cooperation and interaction as part of the development of the Russian healthcare system for the benefit of a common goal – improving people’s quality of life.